Crossmark

Evidence-based recommendations regarding risk reduction practices for people at risk of or with breast cancer-related lymphedema: consensus from an expert panel

Crossref DOI link: https://doi.org/10.1007/s12032-024-02510-6

Published Online: 2024-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brunelle, Cheryl L.

Jackson, Katherine

Shallwani, Shirin M.

Hunley, Julie H.

Kennedy, Anna

Fench, Sarah

Hill, Alexandra

Paskett, Electra D.

Rush, Katrina

Thiadens, Saskia R. J.

White, Joan

Stewart, Paula
Funding

Funding for this research was provided by:

American Cancer Society

Lymphology Association of North America
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 27 June 2024

Accepted: 18 September 2024

First Online: 23 October 2024

Declarations

:

: All authors received travel support from the American Cancer Society and the Lymphology Association of North America.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below